Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117775323 | 11777532 | 3 | F | 2014 | 20160628 | 20151125 | 20160711 | EXP | US-SA-2015SA188319 | AVENTIS | 70.00 | YR | E | F | Y | 0.00000 | 20160711 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117775323 | 11777532 | 1 | PS | LANTUS | INSULIN GLARGINE | 1 | Unknown | DOSE:60 UNIT(S) | 5F424A | 21081 | QD | ||||||||
| 117775323 | 11777532 | 2 | SS | LANTUS | INSULIN GLARGINE | 1 | Unknown | DOSE:40 UNIT(S) | 5F424A | 21081 | BID | ||||||||
| 117775323 | 11777532 | 3 | SS | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | Unknown | DOSE:60 UNIT(S) | U | UNKNOWN | 21081 | QD | |||||||
| 117775323 | 11777532 | 4 | SS | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | Unknown | U | UNK | 21081 | 40 | MG | BID | ||||||
| 117775323 | 11777532 | 5 | SS | APIDRA SOLOSTAR | INSULIN GLULISINE | 1 | Unknown | DOSE:40 UNIT(S) | 5F18723A | 21629 | BID | ||||||||
| 117775323 | 11777532 | 6 | C | SOLOSTAR | DEVICE | 1 | 0 | QD | |||||||||||
| 117775323 | 11777532 | 7 | C | SOLOSTAR | DEVICE | 1 | 0 | QD | |||||||||||
| 117775323 | 11777532 | 8 | C | SOLOSTAR | DEVICE | 1 | 0 | BID | |||||||||||
| 117775323 | 11777532 | 9 | C | NOVOLOG | INSULIN ASPART | 1 | TAKING BEFORE A MEAL AFTER DOING A ^READING^. | 0 | |||||||||||
| 117775323 | 11777532 | 10 | C | NOVOLOG | INSULIN ASPART | 1 | 0 | ||||||||||||
| 117775323 | 11777532 | 11 | C | FLEXPEN | UNSPECIFIED INGREDIENT | 1 | 0 | ||||||||||||
| 117775323 | 11777532 | 12 | C | NASONEX | MOMETASONE FUROATE | 1 | 0 | ||||||||||||
| 117775323 | 11777532 | 13 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 117775323 | 11777532 | 14 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 117775323 | 11777532 | 15 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | 40 | MG | QD | |||||||||
| 117775323 | 11777532 | 16 | C | LOSARTAN. | LOSARTAN | 1 | 0 | 50 | MG | TABLET | |||||||||
| 117775323 | 11777532 | 17 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | 40 | MG | TABLET | |||||||||
| 117775323 | 11777532 | 18 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | 500 | MG | TABLET | |||||||||
| 117775323 | 11777532 | 19 | C | POTASSIUM | POTASSIUM | 1 | 0 | 400 | MG | TABLET | |||||||||
| 117775323 | 11777532 | 20 | C | NEVANAC | NEPAFENAC | 1 | 1 DROP IN EACH EYE A DAY | 0 | |||||||||||
| 117775323 | 11777532 | 21 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | ONE SPRAY IN EACH NOSTRIL.?FORM: NASAL SPRAY | 0 | |||||||||||
| 117775323 | 11777532 | 22 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | HAND HELD AEROLIZER?3 SPRAYS | 0 | |||||||||||
| 117775323 | 11777532 | 23 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117775323 | 11777532 | 1 | Type 2 diabetes mellitus |
| 117775323 | 11777532 | 2 | Type 2 diabetes mellitus |
| 117775323 | 11777532 | 3 | Type 2 diabetes mellitus |
| 117775323 | 11777532 | 4 | Type 2 diabetes mellitus |
| 117775323 | 11777532 | 5 | Type 2 diabetes mellitus |
| 117775323 | 11777532 | 6 | Type 2 diabetes mellitus |
| 117775323 | 11777532 | 7 | Type 2 diabetes mellitus |
| 117775323 | 11777532 | 8 | Type 2 diabetes mellitus |
| 117775323 | 11777532 | 15 | Gastrooesophageal reflux disease |
| 117775323 | 11777532 | 16 | Hypertension |
| 117775323 | 11777532 | 17 | Blood cholesterol increased |
| 117775323 | 11777532 | 18 | Electrolyte imbalance |
| 117775323 | 11777532 | 19 | Electrolyte imbalance |
| 117775323 | 11777532 | 20 | Eye inflammation |
| 117775323 | 11777532 | 22 | Asthma |
| 117775323 | 11777532 | 23 | Dyspnoea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117775323 | 11777532 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117775323 | 11777532 | Anaemia | |
| 117775323 | 11777532 | Colorectal cancer | |
| 117775323 | 11777532 | Colostomy | |
| 117775323 | 11777532 | Decreased appetite | |
| 117775323 | 11777532 | Feeling cold | |
| 117775323 | 11777532 | Haemoglobin decreased | |
| 117775323 | 11777532 | Headache | |
| 117775323 | 11777532 | Hyperhidrosis | |
| 117775323 | 11777532 | Hypoglycaemia | |
| 117775323 | 11777532 | Injection site induration | |
| 117775323 | 11777532 | Off label use | |
| 117775323 | 11777532 | Pain of skin | |
| 117775323 | 11777532 | Stomal hernia | |
| 117775323 | 11777532 | Tremor | |
| 117775323 | 11777532 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117775323 | 11777532 | 1 | 201306 | 0 | ||
| 117775323 | 11777532 | 3 | 201408 | 0 | ||
| 117775323 | 11777532 | 4 | 201604 | 0 | ||
| 117775323 | 11777532 | 5 | 201306 | 0 | ||
| 117775323 | 11777532 | 6 | 201408 | 0 | ||
| 117775323 | 11777532 | 7 | 201604 | 0 | ||
| 117775323 | 11777532 | 8 | 201306 | 0 | ||
| 117775323 | 11777532 | 15 | 2014 | 0 | ||
| 117775323 | 11777532 | 16 | 2013 | 0 | ||
| 117775323 | 11777532 | 17 | 2013 | 0 | ||
| 117775323 | 11777532 | 20 | 2016 | 0 |